Asian women with endocrine-resistant breast cancer benefit from combination therapy

[News]

Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine...

More... (http://www.medicalnewstoday.com/releases/304317.php)